Casdin Capital
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1350 Avenue of the Americas Ste 2600, Ne...Phone Number
(212) 897-5430Website
www.casdincapital.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
3
2
2
About Casdin Capital
Casdin Capital, LLC was founded in 2011 and brings a deep understanding, expertise and long-term perspective to financing the next generation of life science innovation. Specific only to the firm's diagnostics and molecular information portfolio, Casdin Capital has invested in many of the leading pioneers, including but not limited to Foundation Medicine, Invitae, Adaptive Biotechnologies, Flatiron Health and 23andMe. In addition, Eli Casdin currently serves on the board of directors of Exact Sciences, a leader in the field of molecular screening for cancer.Explore more
Casdin Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Casdin Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Casdin Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at Casdin Capital
Check if Casdin Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Casdin Capital launches new products
Earning: See what the market has to say on Casdin Capital recently announced quarterly report
Click to see if Casdin Capital had a recent Job posting/layoffs
Check out if Casdin Capital is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Casdin Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Casdin Capital
Find 3 more new buyers
Compare Similar Companies to Casdin Capital
Compare insights from companies similar to Casdin Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5M
11-50
Private
-
1984
PF
Pascal FortinEntrepreneur-in-Residence. President and Chief Scientific Officer, Stealth NewCo
Company Profile Activity
Activity Insights
Casdin Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Casdin Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Casdin Capital.
Casdin Capital Tech Stack
A closer look at the technologies used by Casdin Capital
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Open Position
Casdin Capital News & Media
Thyme Care Raises $60M in Series B Funding
Thyme Care, a Nashville, TN-based value-based cancer care partner, raised $60M in Series B funding. The round, which brought total capital raised to over $80M, was co-led by Town Hall Ventures and Foresite Capital, with participation from current investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital, and Frist Cressey Ventures. David Whelan, co-founder and general partner at Town Hall Ventures, and Elizabeth Canis, executive advisor […] The post Thyme Care Raises $60M in Series BFunction Oncology Raises $28M in Series A Financing
Function Oncology, a San Diego, CA-based precision medicine company, raised $28M in Series A funding. The round was led by a16z and Section 32, with participation from Casdin Capital and Alexandria Venture Investments. Led by Srinath Sampath, M.D., Ph.D., MPhil, co-founder and chief executive officer, Function Oncology is a precision medicine company that leverages a […] The post Function Oncology Raises $28M in Series A Financing appeared first on FinSMEs.Flare Therapeutics Raises $123M in Series B Financing
Flare Therapeutics, a Cambridge, MA-based biotechnology company targeting transcription factors, raised $123M in Series B funding. The round was led by GordonMD Global Investments LP and Pfizer Ventures, with participation from existing investors Boxer Capital, Casdin Capital, Eventide Asset Management, Invus Financial Advisors, Nextech Invest and Third Rock Ventures and new investors Agent Capital, Eli Lilly […] The post Flare Therapeutics Raises $123M in Series B Financing appeared first on FiMubadala Capital/Casdin Capital Joins $135M Series B For Chroma Medicine
Chroma Medicine, a Cambridge, MA-based genomic medicine company, raised $135M in Series B funding. The round was led by GV, with participation... Read More The post Mubadala Capital/Casdin Capital Joins $135M Series B For Chroma Medicine appeared first on citybiz.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Casdin Capital
Sign Up For FreeTo access detailed company insights
Casdin Capital, LLC was founded in 2011 and brings a deep understanding, expertise and long-term perspective to financing the next generation of life science innovation. Specific only to the firm's diagnostics and molecular information portfolio, Casdin Capital has invested in many of the leading pioneers, including but not limited to Foundation Me... Read More
